BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/2/2022 12:11:47 PM | Browse: 510 | Download: 1228
 |
Received |
|
2021-12-13 07:31 |
 |
Peer-Review Started |
|
2021-12-13 07:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-01-23 06:34 |
 |
Revised |
|
2022-02-01 10:34 |
 |
Second Decision |
|
2022-04-20 02:21 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-04-25 19:54 |
 |
Articles in Press |
|
2022-04-25 19:54 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-04-13 04:10 |
 |
Typeset the Manuscript |
|
2022-05-20 08:19 |
 |
Publish the Manuscript Online |
|
2022-06-02 12:11 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Serological biomarkers for management of primary sclerosing cholangitis
|
Manuscript Source |
Invited Manuscript |
All Author List |
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos and Maria Papp |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund |
138041 |
EFOP projects co-financed by the European Union and the European Social Fund |
EFOP-3.6.1-16-2016-00022 |
|
Corresponding Author |
Maria Papp, DSc, FEBG, MD, PhD, Full Professor, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt, Debrecen H-4032, Hajdu-Bihar, Hungary. papp.maria@med.unideb.hu |
Key Words |
Primary sclerosing cholangitis; Hepatobiliary; Serological biomarker; Immunoglobulin; Inflammatory; Tissue remodeling |
Core Tip |
Recent advances in biomarker research may help clinicians identify relevant subgroups of primary sclerosing cholangitis (PSC) and assist everyday clinical work-up. However, a diagnostic biomarker is still an unmet need. On the other hand, several biomarkers have been reported to predict outcome in PSC; however, most of them have not been validated by subsequent studies. The IgA type anti-glycoprotein 2 antibody is the first one to be supported by a satisfactory number of clinical studies and could be incorporated into clinical practice. These discoveries also reveal different aspects of PSC providing with potential therapeutic targets. |
Publish Date |
2022-06-02 12:11 |
Citation |
Tornai D, Ven PL, Lakatos PL, Papp M. Serological biomarkers for management of primary sclerosing cholangitis. World J Gastroenterol 2022; 28(21): 2291-2301 |
URL |
https://www.wjgnet.com/1007-9327/full/v28/i21/2291.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v28.i21.2291 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345